Marc Tessier-Lavigne, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 13,334 shares at $260.20 ($3.5M) on 2013-05-06, disclosed to the SEC on 2013-05-08.
Open-market sale of $3.5M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $260.20 | 8,334 | $2.2M | 62.3% |
| 2 | $260.75 | 800 | $209K | 6.0% |
| 3 | $261.53 | 1,700 | $445K | 12.8% |
| 4 | $262.49 | 1,700 | $446K | 12.8% |
| 5 | $263.50 | 500 | $132K | 3.8% |
| 6 | $264.17 | 300 |
| $79K |
| 2.3% |
| Total | $260.91 avg | 13,334 | $3.5M | 100% |
| Filing → |
| REGN | SELL | 2022-10-03 | $10.2M | — | Filing → |
| DNLI | SELL | 2022-09-30 | $1.2M | — | Filing → |
| DNLI | SELL | 2022-08-25 | $632K | — | Filing → |